Effect of serum blocking factors on leukocyte adherence inhibition in breast cancer patients. Specificity and correlation with tumor burden
暂无分享,去创建一个
[1] G. Heppner,et al. In vitro studies on cell‐mediated immunity following surgery in mice sensitized to syngeneic mammary tumors , 2006, International journal of cancer.
[2] T. Fujisawa,et al. Leukocyte adherence inhibition by soluble tumor antigens in breast cancer patients , 1977, Cancer.
[3] S. Golub,et al. Fetal calf serum-induced blastogenic and cytotoxic responses of human lymphocytes. , 1976, Cancer research.
[4] C. Ross,et al. Leukocyte migration inhibition by cancer patients' sera , 1976, International journal of cancer.
[5] D. Thomson,et al. Tube leukocyte (monocyte) adherence inhibition assay for the detection of anti‐tumour immunity. III. “Blockade” of monocyte reactivity by excess free antigen and immune complexes in advanced cancer patients , 1976, International journal of cancer.
[6] K. Hellström,et al. Tumor-associated blocking factors: isolation from sera of tumor-bearing mice. , 1976, Journal of immunology.
[7] A. E. Bray. The use of serum-blocking factor as an indicator of residual tumor following primary excision. , 1975, The Journal of surgical research.
[8] N. Davis,et al. Leukocyte adherence inhibition and specific immunoreactivity in malignant melanoma , 1975, International journal of cancer.
[9] G. Steele,et al. COLON CARCINOMA ANTIGENS IN THE RAT * , 1975, Annals of the New York Academy of Sciences.
[10] A. Mantovani,et al. On the nature of blocking factors and their lymphoid target cells in an allogeneic tumor system. , 1975, European journal of cancer.
[11] D. Kern,et al. Serologic evidence for cross‐reacting antigens in two carcinogen‐induced murine sarcomas , 1975, International journal of cancer.
[12] R. Herberman,et al. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human breast carcinoma. , 1974, Journal of the National Cancer Institute.
[13] W. J. Halliday,et al. Cell-mediated immunity and specific serum factors in human cancer: the leukocyte adherence inhibition test. , 1974, Journal of the National Cancer Institute.
[14] R. Rees,et al. Immune response to adenovirus 12-induced tumour antigens, as measured in vitro by the macrophage migration inhibition test. , 1973, European journal of cancer.
[15] G. Heppner,et al. Cell‐mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma , 1973, International journal of cancer.
[16] G. Currie,et al. Serum Mediated Inhibition of the Immunological Reactions of the Patient to his Own Tumour: A Possible Role for Circulating Antigen , 1972, British Journal of Cancer.
[17] J. Sinkovics,et al. Disappearance after chemotherapy of blocking serum factors as measured in vitro with lymphocytes cytotoxic to tumor cells , 1972, Cancer.
[18] W. J. Halliday,et al. Leukocyte adherence inhibition: A simple test for cell‐mediated tumour immunity and serum blocking factors , 1972, International journal of cancer.
[19] M. Meltzer,et al. Tumor-specific antigen solubilized by hypertonic potassium chloride. , 1971, Journal of the National Cancer Institute.
[20] I. Hellstrom,et al. Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[21] H. Sjögren,et al. Blocking of cell‐mediated tumor immunity by sera from patients with growing neoplasms , 1971, International journal of cancer.
[22] W. J. Halliday. Blocking effect of serum from tumor-bearing animals on macrophage migration inhibition with tumor antigens. , 1971, Journal of immunology.
[23] K. Hellström,et al. Studies on cellular immunity and its serum‐mediated inhibition in moloney‐virus‐induced mouse sarcomas , 1969, International journal of cancer.
[24] H. Morris,et al. Some factors affecting carbohydrate metabolism in hepatic tissues of different growth rates , 1969, International journal of cancer.